Taro to Announce Second Quarter Results on November 5, 2018
October 29 2018 - 03:15PM
Business Wire
Earnings Call to be Conducted Tuesday,
November 6 at 8:00 am EST
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today
that it plans to release its financial results for the quarter and
six months ended September 30, 2018, on Monday, November 5,
2018.
The Company will conduct an earnings call at 8:00 am EST on
Tuesday, November 6, 2018, where senior management will discuss the
Company’s performance and answer questions from participants.
The earnings release will be accessible on Taro’s website at
www.taro.com.
Earnings Call (8:00 am EST
on Tuesday, November 6, 2018)
To participate in this conference call, please dial the numbers
provided below five to ten minutes ahead of the scheduled start
time. The operator will provide instructions on asking questions
before the call. You can also hear the call via an audio webcast,
details of which will be announced later on the Company website,
www.taro.com. A transcript of this earnings call will also be
available on the website.
Summary of events
Event Date and time
Telephone number/ website Earnings release
November 5, 2018 (AMC)
www.taro.com
Earnings conference call 8:00 am EST
November 6, 2018
Participant Toll-Free Dial-In Number: +1
(844) 421-0601
Participant International Dial-In Number:
+1 (716) 247-5800
Conference ID: 2871389
Via audio webcast, details of which will
be made available on www.taro.com
Replay of conference call November 6, 2018 to
November 18, 2018
+ 1 (855) 859-2056 or +1 (404)
537-3406
Conference ID: 2871389
Via audio webcast playback, details of
which will be made available on www.taro.com
About Taro
Taro Pharmaceutical Industries Ltd. is a multinational,
science-based pharmaceutical company, dedicated to meeting the
needs of its customers through the discovery, development,
manufacturing and marketing of the highest quality healthcare
products. For further information on Taro Pharmaceutical Industries
Ltd., please visit the Company’s website at www.taro.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181029005695/en/
Taro Pharmaceutical Industries Ltd.Mariano A.
BalaguerVP, CFO(914)
345-9001Mariano.Balaguer@taro.comorWilliam J. CooteAVP,
Business Finance, Treasurer and Investor Relations(914)
345-9001William.Coote@taro.com
Taro Pharmaceutical Indu... (NYSE:TARO)
Historical Stock Chart
From Feb 2024 to Mar 2024
Taro Pharmaceutical Indu... (NYSE:TARO)
Historical Stock Chart
From Mar 2023 to Mar 2024